370 related articles for article (PubMed ID: 22251703)
41. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.
Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
J Leukoc Biol; 2010 Jan; 87(1):117-25. PubMed ID: 19843574
[TBL] [Abstract][Full Text] [Related]
42. 9-Phenanthrol enhances the generation of an CD8
Hartmann AK; Aranda Lopez P; Zajac M; Freichel M; Schild H; Radsak MP; Stassen M
J Dermatol Sci; 2017 Sep; 87(3):260-267. PubMed ID: 28823644
[TBL] [Abstract][Full Text] [Related]
43. pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG.
Wu J; Li S; Li T; Lv X; Zhang M; Zang G; Qi C; Liu YJ; Xu L; Chen J
J Immunol Res; 2019; 2019():1749803. PubMed ID: 31093508
[TBL] [Abstract][Full Text] [Related]
44. Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy.
Broomfield SA; van der Most RG; Prosser AC; Mahendran S; Tovey MG; Smyth MJ; Robinson BW; Currie AJ
J Immunol; 2009 May; 182(9):5217-24. PubMed ID: 19380767
[TBL] [Abstract][Full Text] [Related]
45. Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells.
Colisson R; Barblu L; Gras C; Raynaud F; Hadj-Slimane R; Pique C; Hermine O; Lepelletier Y; Herbeuval JP
Blood; 2010 Mar; 115(11):2177-85. PubMed ID: 20007807
[TBL] [Abstract][Full Text] [Related]
46. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells.
Karrich JJ; Jachimowski LC; Libouban M; Iyer A; Brandwijk K; Taanman-Kueter EW; Nagasawa M; de Jong EC; Uittenbogaart CH; Blom B
Blood; 2013 Oct; 122(17):3001-9. PubMed ID: 24014244
[TBL] [Abstract][Full Text] [Related]
48. Plasmacytoid dendritic cells protect against immune-mediated acute liver injury via IL-35.
Koda Y; Nakamoto N; Chu PS; Ugamura A; Mikami Y; Teratani T; Tsujikawa H; Shiba S; Taniki N; Sujino T; Miyamoto K; Suzuki T; Yamaguchi A; Morikawa R; Sato K; Sakamoto M; Yoshimoto T; Kanai T
J Clin Invest; 2019 Jul; 129(8):3201-3213. PubMed ID: 31264967
[TBL] [Abstract][Full Text] [Related]
49. Plasmacytoid dendritic cells orchestrate TLR7-mediated innate and adaptive immunity for the initiation of autoimmune inflammation.
Takagi H; Arimura K; Uto T; Fukaya T; Nakamura T; Choijookhuu N; Hishikawa Y; Sato K
Sci Rep; 2016 Apr; 6():24477. PubMed ID: 27075414
[TBL] [Abstract][Full Text] [Related]
50. CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues.
Sisirak V; Vey N; Vanbervliet B; Duhen T; Puisieux I; Homey B; Bowman EP; Trinchieri G; Dubois B; Kaiserlian D; Lira SA; Puisieux A; Blay JY; Caux C; Bendriss-Vermare N
Blood; 2011 Nov; 118(19):5130-40. PubMed ID: 21937703
[TBL] [Abstract][Full Text] [Related]
51. Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain.
Cao H; Dai P; Wang W; Li H; Yuan J; Wang F; Fang CM; Pitha PM; Liu J; Condit RC; McFadden G; Merghoub T; Houghton AN; Young JW; Shuman S; Deng L
PLoS One; 2012; 7(5):e36823. PubMed ID: 22606294
[TBL] [Abstract][Full Text] [Related]
52. Impaired activation of plasmacytoid dendritic cells
Monti M; Ferrari G; Grosso V; Missale F; Bugatti M; Cancila V; Zini S; Segala A; La Via L; Consoli F; Orlandi M; Valerio A; Tripodo C; Rossato M; Vermi W
Front Immunol; 2023; 14():1227648. PubMed ID: 38239354
[TBL] [Abstract][Full Text] [Related]
53. PACSIN1 regulates the TLR7/9-mediated type I interferon response in plasmacytoid dendritic cells.
Esashi E; Bao M; Wang YH; Cao W; Liu YJ
Eur J Immunol; 2012 Mar; 42(3):573-9. PubMed ID: 22488361
[TBL] [Abstract][Full Text] [Related]
54. X-Chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-mediated IFN-α production of plasmacytoid dendritic cells from women.
Laffont S; Rouquié N; Azar P; Seillet C; Plumas J; Aspord C; Guéry JC
J Immunol; 2014 Dec; 193(11):5444-52. PubMed ID: 25339659
[TBL] [Abstract][Full Text] [Related]
55. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
56. Plasmacytoid dendritic cell heterogeneity is defined by CXCL10 expression following TLR7 stimulation.
Marsman C; Lafouresse F; Liao Y; Baldwin TM; Mielke LA; Hu Y; Mack M; Hertzog PJ; de Graaf CA; Shi W; Groom JR
Immunol Cell Biol; 2018 Nov; 96(10):1083-1094. PubMed ID: 29870118
[TBL] [Abstract][Full Text] [Related]
57. TLR7 mediated viral recognition results in focal type I interferon secretion by dendritic cells.
Saitoh SI; Abe F; Kanno A; Tanimura N; Mori Saitoh Y; Fukui R; Shibata T; Sato K; Ichinohe T; Hayashi M; Kubota K; Kozuka-Hata H; Oyama M; Kikko Y; Katada T; Kontani K; Miyake K
Nat Commun; 2017 Nov; 8(1):1592. PubMed ID: 29150602
[TBL] [Abstract][Full Text] [Related]
58. Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T-cell cross-priming.
Fehres CM; Bruijns SC; van Beelen AJ; Kalay H; Ambrosini M; Hooijberg E; Unger WW; de Gruijl TD; van Kooyk Y
Eur J Immunol; 2014 Aug; 44(8):2415-24. PubMed ID: 24825342
[TBL] [Abstract][Full Text] [Related]
59. Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons.
Gregorio J; Meller S; Conrad C; Di Nardo A; Homey B; Lauerma A; Arai N; Gallo RL; Digiovanni J; Gilliet M
J Exp Med; 2010 Dec; 207(13):2921-30. PubMed ID: 21115688
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice.
Ito H; Ando T; Ogiso H; Arioka Y; Seishima M
Cancer Immunol Immunother; 2015 Apr; 64(4):429-36. PubMed ID: 25567751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
